Arcoxia "Coming Soon" Journal Ads Running As User Fee Date Approaches
This article was originally published in The Pink Sheet Daily
Executive Summary
The ad first appeared in medical journals in early September, well ahead of the Oct. 30 PDUFA date for the COX-2 inhibitor. Merck says the ad does not reflect expectations of a particular FDA review decision but rather is standard industry practice.